These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9436697)

  • 1. Endometrial ultrasonography as a predictor of pregnancy in an in-vitro fertilization programme after ovarian stimulation and gonadotrophin-releasing hormone and gonadotrophins.
    Oliveira JB; Baruffi RL; Mauri AL; Petersen CG; Borges MC; Franco JG
    Hum Reprod; 1997 Nov; 12(11):2515-8. PubMed ID: 9436697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial ultrasonography as a predictor of pregnancy in an in-vitro fertilization programme.
    Oliveira JB; Baruffi RL; Mauri AL; Petersen CG; Campos MS; Franco JG
    Hum Reprod; 1993 Aug; 8(8):1312-5. PubMed ID: 8408534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
    Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
    Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effect of a homogeneous hyperechogenic endometrial sonographic pattern, despite adequate endometrial thickness on pregnancy rates following in-vitro fertilization.
    Check JH; Lurie D; Dietterich C; Callan C; Baker A
    Hum Reprod; 1993 Aug; 8(8):1293-6. PubMed ID: 8408530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of endometrial receptivity during in-vitro fertilization using three-dimensional power Doppler ultrasound.
    Järvelä IY; Sladkevicius P; Kelly S; Ojha K; Campbell S; Nargund G
    Ultrasound Obstet Gynecol; 2005 Dec; 26(7):765-9. PubMed ID: 16270378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of three-dimensional power Doppler ultrasound parameters measured on hCG day in the prediction of pregnancy during in vitro fertilization treatment.
    Zhang T; He Y; Wang Y; Zhu Q; Yang J; Zhao X; Sun Y
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():66-71. PubMed ID: 27254812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound assessment of endometrial thickness: correlation with ovarian stimulation and pregnancy rates in IVF cycles.
    Giannaris D; Zourla A; Chrelias C; Loghis C; Kassanos D
    Clin Exp Obstet Gynecol; 2008; 35(3):190-3. PubMed ID: 18754290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian response is a better predictor of clinical pregnancy rate following embryo transfer than is thin endometrium or presence of an endometrioma.
    Coelho Neto MA; Martins WP; Lima ML; Barbosa MA; Nastri CO; Ferriani RA; Navarro PA
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):501-5. PubMed ID: 25914103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
    Albuquerque LE; Saconato H; Maciel MC
    Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between pregnancy rates following in vitro fertilization or intracytoplasmic sperm injection and endometrial thickness and pattern.
    Rashidi BH; Sadeghi M; Jafarabadi M; Tehrani Nejad ES
    Eur J Obstet Gynecol Reprod Biol; 2005 Jun; 120(2):179-84. PubMed ID: 15925048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of endometrial thickness on IVF/ICSI outcome.
    Kovacs P; Matyas S; Boda K; Kaali SG
    Hum Reprod; 2003 Nov; 18(11):2337-41. PubMed ID: 14585884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonographic appearance of the endometrium: the predictive value for the outcome of in-vitro fertilization in stimulated cycles.
    Khalifa E; Brzyski RG; Oehninger S; Acosta AA; Muasher SJ
    Hum Reprod; 1992 May; 7(5):677-80. PubMed ID: 1639988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological evaluation of endometrium on the day of oocyte retrieval after gonadotrophin-releasing hormone agonist-follicle stimulating hormone ovulation induction for in-vitro fertilization.
    Lass A; Peat D; Avery S; Brinsden P
    Hum Reprod; 1998 Nov; 13(11):3203-5. PubMed ID: 9853881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical applications of different doses of leuprorelin acetate in in vitro fertilization-embryo transfer].
    Wang L; Zhang WX; Jiang H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):910-4. PubMed ID: 23324190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Endometrial Thickness on the Day of Human Chorionic Gonadotrophin (hCG) Administration on Ongoing Pregnancy Rate in Patients with Different Ovarian Response.
    Bu Z; Sun Y
    PLoS One; 2015; 10(12):e0145703. PubMed ID: 26717148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.